Strategies to maximize influenza vaccine impact in older adults
- PMID: 30153995
- DOI: 10.1016/j.vaccine.2018.08.040
Strategies to maximize influenza vaccine impact in older adults
Abstract
Older adults are disproportionately affected by influenza morbidity and mortality. In most high income countries, influenza vaccine policies target persons age ≥65 years for influenza vaccination. Many low-resource settings do not utilize seasonal influenza vaccination. Barriers to influenza prevention among older adults around the globe are multiple and some vary between high- and low-resource settings. To maximize influenza prevention in the older adult population, gaps in influenza vaccination coverage and improvements in vaccine efficacy are needed. The focus of this article is on the data for currently available vaccine strategies to maximize influenza vaccine impact, with a focus on high-resource settings. We also discuss novel influenza vaccine strategies needed for older adults worldwide.
Keywords: Adjuvants; Adult; Aged; Immunocompromised host; Immunologic; Influenza vaccines; Influenza, Human; Vaccination.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness.Vaccine. 2017 Aug 24;35(36):4681-4686. doi: 10.1016/j.vaccine.2017.07.053. Epub 2017 Jul 25. Vaccine. 2017. PMID: 28754488
-
Influenza vaccine uptake among older adults in Brazil: Socioeconomic equality and the role of preventive policies and public services.J Infect Public Health. 2020 Feb;13(2):211-215. doi: 10.1016/j.jiph.2019.07.022. Epub 2019 Aug 18. J Infect Public Health. 2020. PMID: 31431425
-
Trends in influenza vaccination coverage rates in South Korea from 2005 to 2014: Effect of public health policies on vaccination behavior.Vaccine. 2018 Jun 14;36(25):3666-3673. doi: 10.1016/j.vaccine.2018.05.024. Epub 2018 May 5. Vaccine. 2018. PMID: 29739721
-
Understanding the unique characteristics of seasonal influenza illness to improve vaccine uptake in the US.Vaccine. 2018 Nov 19;36(48):7276-7285. doi: 10.1016/j.vaccine.2018.10.027. Epub 2018 Oct 23. Vaccine. 2018. PMID: 30366802 Review.
-
Influenza vaccines provide diminished protection but are cost-saving in older adults.J Intern Med. 2010 Feb;267(2):220-7. doi: 10.1111/j.1365-2796.2009.02201.x. J Intern Med. 2010. PMID: 20175868 Review.
Cited by
-
Sex differences in adverse events following seasonal influenza vaccines: a meta-analysis of randomised controlled trials.J Epidemiol Community Health. 2023 Dec;77(12):791-801. doi: 10.1136/jech-2023-220781. Epub 2023 Sep 21. J Epidemiol Community Health. 2023. PMID: 37734937 Free PMC article.
-
Adult vaccination as part of a healthy lifestyle: moving from medical intervention to health promotion.Ann Med. 2019 Mar;51(2):128-140. doi: 10.1080/07853890.2019.1588470. Epub 2019 Apr 26. Ann Med. 2019. PMID: 31025882 Free PMC article. Review.
-
Peripheral follicular helper T cells in acute viral diseases: a perspective on dengue.Future Virol. 2019 Mar;14(3):161-169. doi: 10.2217/fvl-2018-0197. Epub 2019 Mar 6. Future Virol. 2019. PMID: 31073324 Free PMC article. Review.
-
The cationic liposome CCS/C adjuvant induces immunity to influenza independently of the adaptor protein MyD88.Hum Vaccin Immunother. 2020 Dec 1;16(12):3146-3154. doi: 10.1080/21645515.2020.1750247. Epub 2020 May 13. Hum Vaccin Immunother. 2020. PMID: 32401698 Free PMC article.
-
Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical Trials.JAMA Netw Open. 2021 Feb 1;4(2):e2037640. doi: 10.1001/jamanetworkopen.2020.37640. JAMA Netw Open. 2021. PMID: 33606033 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical